DKK1 and neoplasm: Previous studies have shown that the expression of DKK-1 was down-regulated significantly in human colon cancer, gastric cancer and melanoma, suggesting that DKK-1 may act as a tumor suppressor in these cancers and its role as an antagonist of Wnt signaling is lost in these cancers.